Biography

Prof. Sang Ho Choi

Seoul National University, South Korea


Email: choish@snu.ac.kr


Qualifications

1992  Ph.D., University of Iowa, College of Medicine, USA

1985  M.S., Korea Advanced Institute of Science and Technology, S. Korea

1982  B.A., Seoul National University, S. Korea


Publications (Selected)

  1. Chang, E., Kim, J. W., Jang, C. Y., Kim, J. Y., Kang, S. W., Choi, S. H., ... & Kim, S. H. (2025). Predicting persistent SARS-CoV-2 shedding in immunocompromised patients: a probability-based approach. Infectious Diseases, 1-10.
  2. Sung, D., Choi, G., Ahn, M., Byun, H., Kim, T. Y., Lee, H., ... & Choi, S. H. (2024). Genome-wide phenotypic profiling of transcription factors and identification of novel targets to control the virulence of Vibrio vulnificus. Nucleic Acids Research, gkae1238.
  3. Park, K. H., Huh, J. W., Hong, S. B., Sung, H., Do, K. H., Lee, S. O., ... & Choi, S. H. (2024). Impact of Respiratory Co-Detection in Critically Ill Patients with Pneumocystis jirovecii Pneumonia. American Journal of Respiratory and Critical Care Medicine, (ja).
  4. Choi, W., Lee, H., Wang, Q., Bang, Y. J., & Choi, S. H. (2024). Discovery of a Small-Molecule Inhibitor Targeting the Biofilm Regulator BrpT in Vibrio vulnificus. Journal of Microbiology and Biotechnology, 34(11), 2201.
  5. Park, J. H., Hong, S. B., Huh, J. W., Jung, J., Kim, M. J., Chong, Y. P., ... & Choi, S. H. (2024). Severe Human Parainfluenza Virus Community-and Healthcare-Acquired Pneumonia in Adults at Tertiary Hospital, Seoul, South Korea, 2010–2019. Emerging Infectious Diseases, 30(6), 1088.
  6. Park, J. H., Hong, S. B., Huh, J. W., Jung, J., Kim, M. J., Chong, Y. P., ... & Choi, S. H. (2023, November). 2645. Severe Human Parainfluenza Virus-associated Pneumonia in Adults, Seoul, South Korea, 2010-2019. In Open Forum Infectious Diseases (Vol. 10, No. Suppl 2, pp. ofad500-2257).
  7. Lim, S. Y., Kwon, H. J., Lee, Y. W., Sung, H., Kim, M. N., Choi, S. H., ... & Chong, Y. P. (2023). Routine ophthalmologic examination in Klebsiella pneumoniae bacteremia is not necessary: incidence of and risk factors for ocular involvement. Antimicrobial Agents and Chemotherapy, 67(11), e00822-23.
  8. Kim, Y. K., Eom, Y., Kim, E., Chang, E., Bae, S., Choi, S. H., ... & Kim, Y. S. (2023). Molecular characteristics and prevalence of rifampin resistance in Staphylococcus aureus isolates from patients with bacteremia in South Korea. Antibiotics, 12(10), 1511.
  9. Han, J., Bae, S., Jung, J., Kim, M. J., Chong, Y. P., Choi, S. H., ... & Kim, S. H. (2023). Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study. Medicine, 102(39), e35094.
  10. Kim, T., Hong, S. B., Huh, J. W., Jung, J., Kim, M. J., Chong, Y. P., ... & Choi, S. H. (2022, December). 2192. Clinical and Molecular Characteristics of Severe Respiratory Syncytial Virus Pneumonia in Critically Ill Adults. In Open Forum Infectious Diseases (Vol. 9, No. Supplement_2, pp. ofac492-1811). US: Oxford University Press.
  11. Bae, M., Song, J. S., Kim, J. Y., Bae, S., Jung, J., Choi, S. H., ... & Kim, S. H. (2023). The relationship between organising pneumonia and invasive mould disease in patients with haematologic malignancy. Mycoses, 66(4), 289-298.
  12. Kang, S. W., Kim, J. Y., Park, H., Lim, S. Y., Kim, J., Choi, S. H., ... & Kim, S. H. (2023). Comparison of secondary attack rate and viable virus shedding between patients with SARS‐CoV‐2 Delta and Omicron variants: a prospective cohort study. Journal of Medical Virology, 95(1), e28369.
  13. Ko, D., & Choi, S. H. (2022). Mechanistic understanding of antibiotic resistance mediated by EnvZ/OmpR two-component system in Salmonella enterica serovar Enteritidis. Journal of Antimicrobial Chemotherapy, 77(9), 2419-2428.


Profile Details

https://food.snu.ac.kr/en/members/sang-ho-choi/?ckattempt=1

https://loop.frontiersin.org/people/527858/publications

https://www.researchgate.net/profile/Sang-Ho-Choi-4

Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top